Mechanisms of disease: The epidemiology of bladder cancer
- PMID: 16763645
- DOI: 10.1038/ncpuro0510
Mechanisms of disease: The epidemiology of bladder cancer
Abstract
Mortality from bladder cancer has shown downward trends over the last 2 decades in several western European countries (albeit 10-15 years later than similar trends in the US), but is still increasing in some eastern European countries. Tobacco smoking and occupational exposure to aromatic amines are the two major established environmental risk factors for bladder cancer. Controlling exposure to these factors has been an important contributor to the reduction in bladder cancer mortality, particularly among men. Diet could influence bladder carcinogenesis, as many compounds contained in foods--and their metabolites--are excreted through the urinary tract. Fruit and vegetable consumption was inversely related with bladder cancer in many studies, but no consistent association has emerged between intake of related micronutrients and reduced risk of bladder cancer. Other widely investigated lifestyle habits are probably not associated with risk of developing bladder cancer (e.g. coffee consumption, artificial sweetener use, hair dyes) or are difficult to assess (e.g. fluid intake). Infections and stones in the urinary tract might cause chronic irritation of the bladder epithelium, and thus increase bladder cancer risk. First-degree relatives of bladder cancer patients have a 50-100% increased relative risk of developing the disease, a risk that could be even higher when the proband is diagnosed at an early age.
Comment in
-
Global tobacco consumption: what does it mean for urologists?Nat Clin Pract Urol. 2006 Jun;3(6):289. doi: 10.1038/ncpuro0513. Nat Clin Pract Urol. 2006. PMID: 16763621 No abstract available.
Similar articles
-
Bladder Cancer Working Group report.Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i57-64. doi: 10.1093/jjco/hyq128. Jpn J Clin Oncol. 2010. PMID: 20870921
-
Epidemiology and genetic susceptibility to bladder cancer.BJU Int. 2008 Nov;102(9 Pt B):1207-15. doi: 10.1111/j.1464-410X.2008.07961.x. BJU Int. 2008. PMID: 19035883
-
Declining mortality from bladder cancer in Europe.BJU Int. 2008 Jan;101(1):11-9. doi: 10.1111/j.1464-410X.2007.07239.x. Epub 2007 Oct 30. BJU Int. 2008. PMID: 17971176
-
Etiology of bladder cancer.Semin Urol. 1993 Aug;11(3):113-26. Semin Urol. 1993. PMID: 8210833 Review.
-
Epidemiology of bladder cancer.Hematol Oncol Clin North Am. 1992 Feb;6(1):1-30. Hematol Oncol Clin North Am. 1992. PMID: 1556044 Review.
Cited by
-
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.Cells. 2024 Apr 4;13(7):627. doi: 10.3390/cells13070627. Cells. 2024. PMID: 38607066 Free PMC article.
-
The 15-year national trends of urinary cancers incidence among Iranian men and women; 2005-2020.Int J Equity Health. 2024 Jan 22;23(1):13. doi: 10.1186/s12939-023-02084-1. Int J Equity Health. 2024. PMID: 38254127 Free PMC article.
-
The association between postvoid residual and response to standard therapy in male and female patients with non-muscle-invasive bladder cancer.Curr Urol. 2023 Dec;17(4):251-256. doi: 10.1097/CU9.0000000000000185. Epub 2023 Mar 26. Curr Urol. 2023. PMID: 37994337 Free PMC article.
-
Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study.World J Oncol. 2023 Oct;14(5):382-391. doi: 10.14740/wjon1639. Epub 2023 Sep 20. World J Oncol. 2023. PMID: 37869241 Free PMC article.
-
The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M.Front Cell Infect Microbiol. 2023 Jun 7;13:1182322. doi: 10.3389/fcimb.2023.1182322. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37351184 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical